Please use this identifier to cite or link to this item: http://148.72.244.84:8080/xmlui/handle/xmlui/14534
Title: ynthesis, Green Chemistry Method Characterization of CuFe5O8 Nanocomposite and Assessment of Its Prostate Cancer-Preventive Effects
Authors: Heba.Y. Jassim, Mustafa Hammadi
Keywords: CuFe5O8
Nanoparticles
Origanum
Flutamide
Prostate cancer
PC3 cell line
Issue Date: 2024
Publisher: University of Diyala – College of Education for Pure Sciences
Citation: https://ijas.uodiyala.edu.iq/index.php/IJAS/article/view/41/9
Abstract: In this work,CuFe5O8nanoparticles were prepared to utilize Origanum vulgare leaf extract in a novel, simple, and inexpensive procedure that incorporated three techniques: co-precipitation, ultrasound, and green chemistry. The following methods were used to characterize the produced nanoparticles: XRD, FT-IR, EDX, SEM, and DLS. The average particle size measured in the XRD was 45.101 nm, but the average particle size in the SEM was 64.17 nm. The DLS had particles with an average size of 924.4 nm simultaneously. The efficacy of the synthesised CuFe5O8nanoparticles was evaluated against that of the medication Flutamide, which is administered to treat prostate cancer in Iraq using the PC3 cell line. The results demonstrated the nanoparticles' outstanding efficacy and superiority over the medication. In addition, they were distinguished by their lack of cytotoxicity when measured against the drug's toxicity on red blood cells in the toxicity screening test. If the results indicated that the drug Flutamide had a cell killing value of 6.51, 10.55, 27.69, 32.48, and 52.53) at 24 hours, as well as for CuFe5O8, respectively, the cell killing results were 33.69, 38.53, 46.42, 56.11, and 69.59)% as well value IC50 = 88.46
URI: http://148.72.244.84:8080/xmlui/handle/xmlui/14534
ISSN: 3006-5828
Appears in Collections:المجلة العراقية للعلوم التطبيقية / Iraqi Journal for Applied Science

Files in This Item:
File Description SizeFormat 
9.pdf1.33 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.